Our Company
About Us
About Xanamem
®
Our Team
Recent Annual Reports
Our Strategic Priorities
Corporate Governance
Xanamem
®
The Cortisol Hypothesis
Mechanism of Action
Publications
Clinical Trials
Clinical Development Pipeline
Cognitive Impairment in early Alzheimer’s Disease
Cognitive Impairment in MDD
Anxiety, sleep & behavioral problems in Fragile X Syndrome
Patient Portal
Participate in clinical trials
The XanaCIDD Depression Clinical Trial
The XanaMIA Phase 2b Alzheimer’s Trial
Publications
Investor Centre
Share Price
ASX Announcements
Corporate Presentations
Analyst Reports
Financial Results Centre
Annual General Meeting
General Meeting
Financial Calendar
Right to Receive Documents
Frequently Asked Questions
Investor Contacts
News
Contact Us
News
Latest Summary Corporate Presentation
November 2023
View Presentation
All updates and Media
Media
Corporate Presentations
All
2023
2022
2021
2020
2019
2018
2017
2016
2015
18 Oct 2023
Actinogen
Latest Summary Corporate Presentation October 2023
06 Oct 2023
Actinogen
Company Presentation: ACW CEO presents to Dementia Trials Australia conference
29 Sep 2023
Actinogen
Company Presentation: ACW Clinical Scientist presents to the Asian Society Against Dementia congress
14 Sep 2023
Actinogen
Video interview: [14.46 mins] Xanamem program update
31 Aug 2023
Media
Webcast video recording: Actinogen neuroscience webinar
24 May 2023
Actinogen
Webcast video recording: Actinogen Clinical Trials Science Forum 2023
30 Mar 2023
Actinogen
Oral presentation: CMO presentation at Alzheimer’s and Parkinson’s Disease Conference (AD/PD™) in Gothenburg, Sweden
24 Feb 2023
Actinogen
Company presentation: Spark Plus Biotech Conference in Singapore
09 Jan 2023
Actinogen
Company presentation: Sachs Neuroscience Innovation Forum and other meetings during the JP Morgan Healthcare Conference week
03 Dec 2022
Actinogen
Poster presentation: CTAD conference 2022
16 Nov 2022
Actinogen
Webcast video recording: AGM 16 Nov 2022 ACW Chair’s Address and CEO presentation
16 Nov 2022
Actinogen
Company presentation: AGM 16 Nov 2022 ACW Chair’s Address and CEO presentation
09 Nov 2022
Bell Potter
Webcast video recording: CEO presentation to Bell Potter Healthcare Conference 2022
09 Nov 2022
Actinogen
Company presentation: CEO presentation to Bell Potter Healthcare Conference 2022
03 Nov 2022
SparkPlus
Webinar video recording: CEO presentation at Spark Plus Healthcare Day
03 Nov 2022
Actinogen
Company presentation: CEO presentation to Spark Plus Healthcare Day
24 Oct 2022
ShareCafe
Webinar video recording: CEO presentation at ShareCafe “Hidden Gems”
21 Oct 2022
Actinogen
Company presentation: CEO presentation at ShareCafe “Hidden Gems”
10 Oct 2022
Actinogen
Webcast video recording: Alzheimer’s Disease biomarker study clinical results – Large clinical benefit on FDA-approved measurement of cognition and function in patients with Alzheimer’s Disease
10 Oct 2022
Actinogen
Company presentation: Alzheimer’s Disease biomarker study clinical results – Large clinical benefit on FDA-approved measurement of cognition and function in patients with Alzheimer’s Disease
13 Sep 2022
Actinogen
Company presentation: Xanamem® Clinical Program Update – Alzheimer’s Disease (AD) biomarkers – context and history
11 Aug 2022
Actinogen
Company presentation: CEO presentation for non-deal roadshow investor meetings
03 Aug 2022
Actinogen
Webcast video recording: Actinogen Clinical Trials Science Forum
03 Aug 2022
Actinogen
Company presentation: Actinogen Clinical Trials Science Forum
28 Jul 2022
Actinogen
Company presentation: CEO presentation to Spark Plus Australian Equities Day
14 Jun 2022
Actinogen
Company presentation: CEO presentation for meetings at BIO International Convention
11 May 2022
Actinogen
Company presentation: Bioshares Biotech Summit 2022
04 May 2022
Actinogen
Company presentation: ACW trial results & strategic update presentation
27 Apr 2022
Actinogen
Webcast video recording: XanaMIA Part A Trial positive topline results for Xanamem
27 Apr 2022
Actinogen
Company presentation: XanaMIA Part A Trial positive topline results for Xanamem
01 Mar 2022
Actinogen
Company presentation: CEO presents at Sachs 15th Annual European Life Sciences Conference
10 Jan 2022
Actinogen
Company presentation: CEO presents at San Francisco Healthcare Conference
25 Nov 2021
Actinogen
Webcast video recording: Strategic Update and Capital Raising Investor Presentation
25 Nov 2021
Actinogen
Company presentation: Strategic Update & Capital Raising Investor Presentation
10 Nov 2021
Actinogen
Webcast video recording: AGM 10 Nov 2021 ACW Chair’s Address and CEO presentation
10 Nov 2021
Actinogen
Company presentation: AGM 10 Nov 2021 ACW Chair’s Address and CEO presentation
01 Oct 2021
Actinogen
Company presentation: CEO presentation at conference call on 19 Oct 2021
10 Jun 2021
Actinogen
Company presentation: BIO Digital 2021 (10-11 & 14-18 June 2021)
30 Apr 2021
Actinogen
Teleconference call transcript: Strategic Update and Investor Presentation
21 Apr 2021
Actinogen
Company presentation: Strategic Update and Investor Presentation
27 Nov 2020
Open Briefing
Webcast video recording: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
27 Nov 2020
Actinogen
Audio recording: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
27 Nov 2020
Actinogen
Company presentation: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
02 Nov 2020
Actinogen
Company presentation: New clinical development opportunity Fragile X syndrome
28 Oct 2020
Actinogen
Company presentation: Monsoon Morning Twilight Investor Briefing
19 Oct 2020
Actinogen
Webcast video recording: Conference Call 19 Oct 2020
08 Sep 2020
ASX
Webcast video recording: CEO presentation at ASX Small & Mid-Cap Conference (8-10 Sep 2020)
08 Sep 2020
Actinogen
Company investor presentation: ASX Small & Mid-Cap Conference (8-10 Sep 2020)
31 Jul 2020
Actinogen
Poster presentation: Alzheimer’s Association International Conference (AAIC) Virtual Event (27-31 Jul 2020) Poster presentation by Prof Craig Ritchie, Chair of Actinogen Xanamem Clinical Advisory Board on behalf of Actinogen “Drug Development Summary for Xanamem™, a Potent Inhibitor of the 11β-HSD1 Enzyme”
31 Jul 2020
Finance News Network
Webcast video recording: CEO presentation to FNN CEO Showcase – FNN Online Investor Event, July 2020
15 Jul 2020
Actinogen
Webcast video recording: CEO presentation at Bio Digital 2020
08 Jun 2020
Actinogen
Company presentation: CEO presentation at Bio Digital 2020
08 Jun 2020
Actinogen
Company presentation: CEO presentation for partnering meetings at BIO Digital 2020
29 Apr 2020
Actinogen
Webcast video recording: Prof Craig Ritchie, Chair of ACW’s Xanamem Clinical Advisory Board presentation at AAT/AD-PD 2020
29 Apr 2020
Actinogen
Company presentation summary: AAT-AD/PD 2020
29 Apr 2020
Actinogen
Company presentation: Prof Craig Ritchie, Chair of ACW’s Xanamem Clinical Advisory Board presentation at AAT/AD-PD 2020
29 Jan 2020
Sachs TV
Webcast video recording: CEO presentation at SACHS Neuroscience Innovation Forum in San Francisco, USA
08 Jan 2020
Actinogen
Company presentation: CEO presentation at SACHS Neuroscience Innovation Forum and partnering meetings during JPM week
25 Nov 2019
Actinogen
Webcast video recording: AGM 2019 ACW Managing Directors Address to Shareholders
25 Nov 2019
Actinogen
Company presentation: AGM 2019 Managing Director’s Address to Shareholders
06 Nov 2019
Small Caps
Webcast video recording: CEO presentation at Australian Microcap Investment Conference 2019
25 Sep 2019
Actinogen
Poster presentation: AAIC Satellite Symposium
26 Jun 2019
Actinogen
Company investor presentation: A novel approach to treating cognitive impairment and Alzheimer’s disease
01 May 2019
Actinogen
Company investor presentation: May 2019
21 Mar 2019
Actinogen
Company investor presentation: Mar 2019
07 Jan 2019
Actinogen
Company presentation: ACW presents at SACHS Neuroscience Innovation Forum during JPM Week
06 Jan 2019
Sachs TV
Webcast video recording: CEO presentation at 2nd Annual SACHS Neuroscience Innovation Forum
28 Nov 2018
Actinogen
Company presentation: AGM 28 Nov 2018 ACW Managing Director’s presentation
26 Nov 2018
Actinogen
Company investor presentation: A novel approach to treating cognitive impairment and Alzheimer’s disease
30 Oct 2018
Actinogen
Company presentation: CEO presentation at Australia Biotech Invest & Partnering 2018
17 Oct 2018
Actinogen
Company presentation: CEO presentation at Australian Microcap Investment Conference
25 Sep 2018
FNN Investor Event
Webcast video recording: CEO presentation at FNN investor event – ACW Phase II Alzheimer’s trials
12 Sep 2018
Actinogen
Company presentation: CEO presentation at Singapore Healthcare Investor Day Sep 2018
04 Jun 2018
Actinogen
Company presentation: Presentation at BIO International Convention
30 May 2018
Open Briefing
Teleconference call transcript: Investor Conference Call
30 May 2018
Actinogen
Audio recording: Investor Conference Call
28 May 2018
Actinogen
Company investor presentation: May/Jun 2018
05 Apr 2018
Actinogen
Webcast video recording: Investor Open Briefing March 2018
19 Mar 2018
Actinogen Medical
Company presentation: Investor Open Briefing Mar 2018: Alzheimer Treatment Needs a New Approach – Xanamem
29 Nov 2017
Actinogen
Company presentation: AGM 29 Nov 2017 ACW Managing Director’s presentation
16 Oct 2017
Actinogen
Company investor presentation: Oct 2017
27 Mar 2017
Actinogen
Company investor presentation: March 2017
Back
to top
